Lomitapide for treatment of homozygous familial hypercholesterolemia: The Québec experience-Reference-Cited by-同舟云学术

Lomitapide for treatment of homozygous familial hypercholesterolemia: The Québec experience

Published:2020-10 Issue: Volume:310 Page:54-63
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Aljenedil Sumayah,Alothman Latifah,Bélanger Alexandre M.,Brown Leslie,Lahijanian Zubin,Bergeron Jean,Couture Patrick^ORCID,Baass Alexis,Ruel Isabelle,Brisson Diane,Khoury Etienne,Gaudet Daniel,Genest Jacques

Funder

Amgen

Akcea

Amarin

Ionis Pharmaceuticals Inc

Novartis

Pfizer

Regeneron

The Medecines Company

Sanofi

Canadian Institutes for Health Research, Agriculture and Agri-Food

Dairy Farmers of Canada

Canola Council of Canada

Flax Council of Canada

Dairy Research Institute

Dairy Australia

Danone Institute

Merck

Pﬁzer

Atrium Innovations

Kaneka Corporation

Merck Frosst

Astra Zeneca

Fondation Leducq

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference39 articles.

1. What are we able to achieve today for our patients with homozygous familial hypercholesterolaemia, and what are the unmet needs?;Santos;Atherosclerosis,2014

2. Familial hypercholesterolemia. Acceptor splice site (G-->C) mutation in intron 7 of the LDL-R gene: alternate RNA editing causes exon 8 skipping or a premature stop codon in exon 8. LDL-R(Honduras-1) [LDL-R1061(-1) G-->C];Yu;Atherosclerosis,1999

3. Simplified Canadian definition for familial hypercholesterolemia;Ruel;Can. J. Cardiol.,2018

4. Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia;Kolansky;Am. J. Cardiol.,2008

5. Natural history and cardiac manifestations of homozygous familial hypercholesterolaemia;Haitas;Q. J. Med.,1990

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SADR: Self-Supervised Graph Learning With Adaptive Denoising for Drug Repositioning;IEEE/ACM Transactions on Computational Biology and Bioinformatics;2024-03

2. Advances in familial hypercholesterolemia;Advances in Clinical Chemistry;2024

3. New Biological Therapies for Low-Density Lipoprotein Cholesterol;Canadian Journal of Cardiology;2023-12

4. Primäre Fettstoffwechselstörungen – Stellenwert in aktuellen Dyslipidämieleitlinien und therapeutische Innovationen;Die Innere Medizin;2023-06-06

5. Homozygous Familial Hypercholesterolemia in Canada;JACC: Advances;2023-05